Retapamulin

CAS No. 224452-66-8

Retapamulin ( SB-275833 )

Catalog No. M13596 CAS No. 224452-66-8

An pleuromutilin antibiotic, specifically a protein synthesis inhibitor by interacting on the 50S subunit of the bacterial ribosome.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 49 In Stock
10MG 77 In Stock
50MG 102 In Stock
100MG 151 In Stock
200MG 224 In Stock
500MG 380 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Retapamulin
  • Note
    Research use only, not for human use.
  • Brief Description
    An pleuromutilin antibiotic, specifically a protein synthesis inhibitor by interacting on the 50S subunit of the bacterial ribosome.
  • Description
    An pleuromutilin antibiotic, specifically a protein synthesis inhibitor by interacting on the 50S subunit of the bacterial ribosome; demonstrates high efficacy against certain Gram-positive bacteria including MRSA.Bacterial Infection Approved
  • Synonyms
    SB-275833
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    ribosome
  • Research Area
    Infection
  • Indication
    Bacterial Infection

Chemical Information

  • CAS Number
    224452-66-8
  • Formula Weight
    517.76
  • Molecular Formula
    C30H47NO4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 52 mg/mL
  • SMILES
    O=C(O[C@@H]1C[C@](C=C)(C)[C@@H](O)[C@H](C)[C@]2(CCC3=O)[C@]3([H])[C@]1(C)[C@H](C)CC2)CS[C@@H]4C[C@@](N5C)([H])CC[C@@]5([H])C4
  • Chemical Name
    Acetic acid, 2-[[(3-exo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl]thio]-, (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl ester

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Goldstein EJ, et al. Antimicrob Agents Chemother. 2006 Jan;50(1):379-81.
2. Jones RN, et al. Antimicrob Agents Chemother. 2006 Jul;50(7):2583-6.
3. Champney WS, et al. Antimicrob Agents Chemother. 2007 Sep;51(9):3385-7.
molnova catalog
related products
  • Norlichexanthone

    Norlichexanthone has the potential to treat and/or prevent lifestyle-related diseases such as type 2 diabetes, metabolic syndrome, atherosclerosis and cardiovascular disease.

  • FSL 1

    TLR2/6 agonist (also a putative TLR10 ligand). Activates NF-κB. Induces pro-inflammatory cytokines including IL-8, IL-1β, CCL20 and TNF-α in vitro. Synergizes with IFNγ to induce CXCL10 release from melanoma cells.

  • Inh2-B1

    Inh2-B1 (STK1 inhibitor B1) is a novel specific S aureus Ser/Thr protein kinase (STK1) inhibitor with IC50 of 49 uM.